Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol CD276 contributors: mct - updated : 04-05-2016
HGNC name CD276 antigen
HGNC id 19137
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • an N-terminal signal peptide
  • extracellular V- and C-like Ig domains with 4 conserved cysteine residues
  • a transmembrane region
  • a 45-amino acid cytoplasmic tail
  • conjugated GlycoP
    HOMOLOGY
    interspecies homolog to murine B7h3
    Homologene
    FAMILY
  • immunoglobulin superfamily, B7 immunoregulatory family
  • BTN/MOG family
  • CATEGORY immunity/defense , regulatory
    SUBCELLULAR LOCALIZATION extracellular
        plasma membrane
    basic FUNCTION
  • may be acting as a specific membrane-associated receptor for the association of cytoplasmic droplets with the apical plasma membrane
  • playing a regulatory role in bone formation
  • negative regulator that preferentially affects T cell mediated immune responses
  • function as a regulator of antitumor immunity
  • HLA-G, CD274 and CD276, are secreted from early and term placenta, and have important implications in the mechanisms by which trophoblast immunomodulators modify the maternal immunological environment
  • plays an important role in adaptive immune responses, and may have a novel role in regulating pancreatic tumor progression
  • may have a critical role in primary hepatocellular carcinoma and it may enhance tumor escape from the immune surveillance of CD8(+) T cells
  • might play an important role in angiogenesis of Renal cell carcinoma (RCC) mediated by CD14(+) monocytes
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
    cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s)
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --over  
    in acute myeloid leukemia
    tumoral     --over  
    in oral squamous cell carcinoma (OSCC), and its overexpression correlated with larger tumor size, advanced clinical stage, and low survival rate in OSCC patients
    tumoral     --over  
    in the pancreatic cancer
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    SystemTypeDisorderPubmed
    cancerhemopathy 
    CD276 silencing inhibits tumor progression of mantle cell lymphoma and enhances chemosensitivity
    cancerlung 
    is a promising target for new immunotherapeutic strategies in MM, with particular emphasis in the epithelial variant (malignant mesothelioma (MM)
    ANIMAL & CELL MODELS